INDUCTION OF VARIOUS CYTOCHROMES CYP2B, CYP2C AND CYP3A BY PHENOBARBITONE IN NONHUMAN-PRIMATES

被引:27
|
作者
JONES, CR [1 ]
GUENGERICH, FP [1 ]
RICE, JM [1 ]
LUBET, RA [1 ]
机构
[1] PRI DYNCORP,BIOL CARCINOGENESIS & DEV PROGRAM,FREDERICK,MD 21702
来源
PHARMACOGENETICS | 1992年 / 2卷 / 04期
关键词
D O I
10.1097/00008571-199208000-00003
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Male and female patas (Erythrocebus patas) and cynomolgus (Macaca fascicularis) monkeys were treated with phenobarbitone (PB) and examined for the induction of various cytochrome P450 (P450)-mediated drug metabolizing enzymes. Hydroxylation of testosterone at the 6beta, 2beta, and 15beta positions, metabolites normally associated with CYP3A P450s increased 2- to 5-fold in PB-treated animals. Induction of this P450 family was confirmed by the use of polyclonal antisera directed against the human CYP3A enzymes which inhibited both induced and constitutive 6beta- and 15beta-hydroxylase activities in both species of monkeys. The enzymatic activities testosterone 16beta-hydroxylation, pentoxyresorufin O-dealkylation [PROD], and benzyloxyresorufin O-dealkylation [BZROD] typically associated with the rodent CYP2B subfamily in rodents were also examined. Testosterone 16beta-hydroxylation activity was highly induced up to 15-fold in both species of monkeys to maximal levels similar to those induced in PB-treated male rats. BZROD was similarly induced up to 10-fold in both species of monkeys, but the maximal levels of BZROD achieved were substantially lower than those obtained in PB-treated rats. Finally, PROD yielded an idiosyncratic response showing substantial induction (> 30-fold) in certain patas monkeys (4 out of 8) but minimal (< 5-fold) induction in the other patas monkeys (4 out of 8) or any of the cynomolgus monkeys (0 out of 8). Immunodetection of various cytochromes using polyclonal antisera directed against rat cytochromes confirmed the induction of CYP3A proteins as well as the induction of protein(s) immunologically cross-reactive with rat CYP2B P450s. BZROD, PROD, or testosterone 16beta-hydroxylase activities, were not inhibited by antibody to CYP3A P450s. However, high concentrations of polyclonal antiserum directed against rat CYP2B inhibited all three activities in PB-induced patas monkeys. In contrast, this antiserum failed to inhibit the hydroxylation of testosterone at the 6beta or 2beta positions. Induction of the CYP2C subfamily was observed by immunochemical detection. Interestingly, induction of this subfamily appeared to be more pronounced in cynomolgus than in patas monkeys. Finally, we failed to observe significant sex-dependent differences in P450-mediated enzymatic activities in either control or induced monkeys. These results confirm the induction of a similar spectrum of P450 proteins by PB in non-human primates to that which has previously been observed in rodents.
引用
收藏
页码:160 / 172
页数:13
相关论文
共 50 条
  • [21] Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes
    Graham, RA
    Tyler, LO
    Krol, WL
    Silver, IS
    Webster, LO
    Clark, P
    Chen, LF
    Banks, T
    LeCluyse, EL
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2006, 20 (02) : 69 - 78
  • [22] Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig
    Nannelli, Annalisa
    Chirulli, Vera
    Longo, Vincenzo
    Gervasi, P. Giovanni
    TOXICOLOGY, 2008, 252 (1-3) : 105 - 112
  • [23] Identification of CYP2B and CYP2C genes and their expression levels related to organochlorine compounds in baikal seals (Pusa sibirica)
    Kim, Eun-Young
    Sakamoto, Tomohiro
    Iwata, Hisato
    Tanabe, Shinsuke
    Miyazaki, Nobuyuki
    Petrov, Evgeny A.
    MARINE ENVIRONMENTAL RESEARCH, 2006, 62 : S174 - S175
  • [24] Pronounced induction of CYP4A, CYP2B and CYP3A activity in rats treated with the RXR agonists RWJ-392063 and RWJ-666589
    Krueger, Linda A.
    McMullen, Maggie
    Parkinson, Andrew
    Stahle, Paul
    Streeter, Anthony J.
    DRUG METABOLISM REVIEWS, 2006, 38 : 107 - 107
  • [25] CYP2C18: the orphan in the CYP2C family
    Zubiaur, Pablo
    Gaedigk, Andrea
    PHARMACOGENOMICS, 2022, 23 (16) : 913 - 916
  • [26] The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters
    Huan, JY
    Miranda, CL
    Buhler, DR
    Cheeke, PR
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 151 (02) : 229 - 235
  • [27] Quantitative structure-activity relationship study of binding affinity of azole compounds with CYP2B and CYP3A
    Itokawa, Daisuke
    Nishioka, Tomoki
    Fukushima, Junji
    Yasuda, Tomoyo
    Yamauchi, Aiko
    Chuman, Hiroshi
    QSAR & COMBINATORIAL SCIENCE, 2007, 26 (07): : 828 - 836
  • [28] Is in-vitro induction of CYP2B in rat liver slices (RLS) by phenobarbital (PB) influenced by CYP3A inducing dexamethasone (DEX)?
    Gloeckner, R.
    Rohlaender, S.
    Mueller, D.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 71 - 71
  • [29] T0901317-INDUCED HEPATIC STEATOSIS DRAMATICALLY DECREASES CYP3A AND CYP2C ACTIVITIES IN MICE
    Virgili, Jessica
    Pilote, Sylvie
    Thibault, Camille
    Jubinville, Eric
    Routhier, Joanie
    Drolet, Benoit
    Morissette, Mathieu C.
    Simard, Chantale
    DRUG METABOLISM AND PHARMACOKINETICS, 2018, 33 (01) : S37 - S37
  • [30] SPECIES-DIFFERENCES IN STEREOSELECTIVE METABOLISM OF MEPHENYTOIN BY CYTOCHROME P450 (CYP2C AND CYP3A)
    YASUMORI, T
    CHEN, L
    NAGATA, K
    YAMAZOE, Y
    KATO, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 264 (01): : 89 - 94